Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Eargo, Inc.
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Eargo, Inc.
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Eargo, Inc.
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Support
about
terms
Eargo, Inc.
CIK:
0001719395
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]
Revenue, net
$ 8,270
$ 7,908
$ 28,191
$ 24,331
Cost of revenue
3,937
6,007
17,105
16,231
Gross profit
4,333
1,901
11,086
8,100
Operating expenses:
Research and development
4,742
4,963
14,711
14,689
Sales and marketing
9,281
11,282
35,309
37,306
General and administrative
7,385
11,702
26,739
43,980
Impairment charge
873
0
873
0
Total operating expenses
22,281
27,947
77,632
95,975
Loss from operations
(17,948)
(26,046)
(66,546)
(87,875)
Other income (expense), net:
Interest income
620
419
2,144
480
Interest expense
(549)
Change in fair value of convertible notes
(25,000)
(25,000)
Loss on extinguishment of debt
(772)
Total other income (expense), net
620
(24,581)
2,144
(25,841)
Loss before income taxes
(17,328)
(50,627)
(64,402)
(113,716)
Net loss and comprehensive loss
(17,328)
(50,627)
(64,402)
(113,716)
Net loss attributable to common stockholders, basic and diluted
$ (17,328)
$ (50,627)
$ (64,402)
$ (113,716)
Net loss per share attributable to common stockholders, basic
$ (0.83)
$ (25.7)
$ (3.1)
$ (57.78)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic
20,756,123
1,969,856
20,745,534
1,968,074
Net loss per share attributable to common stockholders, diluted
$ (0.83)
$ (25.7)
$ (3.1)
$ (57.78)
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted
20,756,123
1,969,856
20,745,534
1,968,074
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:
Net loss
$ (64,402)
$ (113,716)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
3,477
4,023
Stock-based compensation
8,677
7,592
Non-cash interest expense and amortization of debt discount
209
Debt issuance costs from convertible notes
5,662
Change in fair value of convertible notes
25,000
Loss on extinguishment of debt
772
Non-cash operating lease expense
734
828
Bad debt expense
409
524
Impairment charge
1,702
0
Changes in operating assets and liabilities:
Accounts receivable
489
10,867
Inventories
650
759
Prepaid expenses and other current assets
2,323
6,869
Other assets
(1,292)
999
Accounts payable
(1,152)
(2,366)
Accrued expenses
(5,897)
1,986
Sales returns reserve
(175)
(12,037)
Settlement liability
(34,372)
Other current and noncurrent liabilities
(124)
89
Operating lease liabilities
(346)
(550)
Net cash used in operating activities
(54,927)
(96,862)
Investing activities:
Purchases of property and equipment
(217)
(2,531)
Capitalized software development costs
(71)
(296)
Net cash used in investing activities
(288)
(2,827)
Financing activities:
Proceeds from stock options exercised
134
Debt repayments
(16,238)
Proceeds from issuance of convertible notes, net of issuance costs paid to lender
99,903
Payment of convertible notes issuance costs to third parties
(5,565)
Payment of deferred transaction costs
(872)
Payment of taxes related to net share settlement of restricted stock units
(29)
Restricted stock units settled in cash
(69)
Net cash provided by financing activities
77,264
Net decrease in cash and cash equivalents
(55,215)
(22,425)
Cash and cash equivalents at beginning of period
101,238
110,500
Cash and cash equivalents at end of period
46,023
88,075
Non-cash operating activities:
Lease liability obtained in exchange for right-of-use asset
1,399
Non-cash investing and financing activities:
Property and equipment and capitalized software costs in accounts payable and accrued liabilities
$ 642
229
Deferred transaction costs included in accounts payable
$ 182
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:
Cash and cash equivalents
$ 46,023
$ 101,238
Accounts receivable, net
1,012
1,910
Inventories
4,386
5,036
Prepaid expenses and other current assets
5,271
7,846
Total current assets
56,692
116,030
Operating lease right-of-use assets
7,327
5,765
Property and equipment, net
4,384
7,441
Intangible assets, net
744
1,063
Goodwill
873
Other assets
606
906
Total assets
69,753
132,078
Current liabilities:
Accounts payable
5,047
6,504
Accrued expenses
6,818
12,715
Sales returns reserve
3,767
3,942
Other current liabilities
1,338
1,462
Lease liability, current portion
624
628
Total current liabilities
17,594
25,251
Lease liability, noncurrent portion
7,030
5,973
Total liabilities
24,624
31,224
Commitments and contingencies (Note 5)
Stockholders' equity:
Common stock; $0.0001 par value; 450,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; 20,762,389 and 20,726,965 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
2
2
Additional paid-in capital
623,828
615,151
Accumulated deficit
(578,701)
(514,299)
Total stockholders' equity
45,129
100,854
Total liabilities and stockholders' equity
$ 69,753
$ 132,078